PATH | VRL
Menu

Find resources

Total results with these characteristics: 1180

Topic: Disease/vaccine specific information

Page 59 of 59
White Paper – Rotavirus: Common, Severe, Devastating, Preventable

This white paper provides a comprehensive source of information on rotavirus disease and vaccines. The 50-page synthesis includes the latest evidence and programmatic information about: rotavirus disease burden; vaccines in global use, nationally …

Author: ROTA Council

Publication date: 2016

WHO Cervical Cancer Prevention and Control Costing (C4P) Tool User Guide

The World Health Organization has developed a generic costing and planning tool for cervical cancer prevention and control to help program planners and managers generate annual cost projections over a five-year period to scale-up human …

Author: World Health Organization

Publication date: 2012

WHO Consultation on Group B Streptococcus Vaccine Development: Report From a Meeting Held on 27-28 April 2016

This article, published in Vaccine, reports the outcome of a World Health Organization technical consultation that considered development pathways for group B Streptococcus (GBS) vaccines. The meeting discussed numerous topics, including disease …

Author: Kobayashi M, Schrag SJ, Alderson MR, et al.

Publication date: 2016

WHO Consultation on Respiratory Syncytial Virus Vaccine Development Report From a World Health Organization Meeting Held on 23–24 March 2015

This article, published in Vaccine, summarizes a World Health Organization-convened respiratory syncytial virus (RSV) vaccine consultation held on March 23 and 24, 2015 in Geneva, Switzerland, which brought together experts from around the world to …

Author: Modjarrad K, Giersing B, Kaslow DC, Smith PG, Moorthy VS, the WHO RSV Vaccine Consultation Expert Group

Publication date: 2015

WHO Expert Consultation on Serotype Composition of Pneumococcal Conjugate Vaccines for Use in Resource-Poor Developing Countries, 26–27 October 2006, Geneva.

Published in the journal Vaccine, this article reports on a World Health Organization expert consultation to formulate a data-driven approach to determine the minimum or optimal formulation of pneumococcal conjugate vaccines, particularly keeping in …

Author: Cherian T

Publication date: 2007

WHO Global Action Plan to Minimize Poliovirus Facility-Associated Risk After Type-Specific Eradication of Wild Polioviruses and Sequential Cessation of Oral Polio Vaccine Use

This is the third edition of the Global Action Plan for eradicating polio. It includes suggested guidelines for the safe handling and containment of poliovirus infectious and potentially infectious materials, with the goal of reduced risk of …

Author: World Health Organization

Publication date: 2015

WHO HPV Laboratory Network

The mission of the World Health Organization (WHO) global human papillomavirus (HPV) Laboratory Network (LabNet) is to contribute to improving quality of laboratory services for effective surveillance and monitoring of HPV vaccination impact, …

Author: World Health Organization

WHO Human Papillomavirus Vaccine Programmatic Resources

This web page provides links to further resources related to human papillomavirus vaccines. Topics include policy and decision making, implementation, and monitoring and surveillance.

Author: World Health Organization

WHO Initiative to Increase Global and Equitable Access to Influenza Vaccine in the Event of a Pandemic: Supporting Developing Country Production Capacity Through Technology Transfer

This article, published in Vaccine, showcases the interim results of the World Health Organization's technology transfer initiative to increase global and equitable access to influenza vaccine in the event of a pandemic. It highlights the progress …

Author: Friede M, Palkonyay L, Alfonso C, et al.

Publication date: 2011

WHO Policy Development Processes for a New Vaccine: Case Study of Malaria Vaccines

This article, published in Malaria Journal, analyzed the World Health Organization policy development process to predict its course for a malaria vaccine. Data needs for a malaria vaccine include safety; the demonstration of efficacy in a range of …

Author: Milstien J, Cardenas V, Cheyne J, Brooks A

Publication date: 2010

WHO Preferred Product Characteristics for Respiratory Syncytial Virus (RSV) Vaccines

This report provides guidance on vaccine development strategies and targets for RSV vaccines. It includes key clinical research and development considerations as well as preferred product characteristics such as indication, target population, …

Author: World Health Organization

Publication date: 2017

WHO Preferred Product Characteristics (PPC) for Malaria Vaccines

This document provides guidance for vaccine manufacturers and funding agencies in refining their product development plans for malaria vaccines. It clarifies the World Health Organization's preferences with regard to many criteria that form part of …

Author: World Health Organization

Publication date: 2014

WHO Prequalified Vaccines

This web page provides a database of vaccines prequalified by the World Health Organization which allows the user to search by manufacturer, vaccine, or country of manufacture. The database is tailored to support immunization program managers, …

Author: World Health Organization

WHO Vaccine Reaction Rates Information Sheets

This web page provides links to information sheets on reaction rates of selected vaccines. The papers are primarily designed for use by national public health officials and immunization program managers. Data from these sheets can be used for the …

Author: World Health Organization

Workshop on Vaccine Pressure and Neisseria Meningitidis, Annecy, France, 9-11 March 2005

This article, published in the journal Vaccine, summarizes a 2005 three-day workshop held in Annecy, France, that reviewed the current state of knowledge regarding Neisseria meningitidis capsule switching and vaccine pressure from capsular …

Author: Alonso JM, Gilmet G, Rouzic EM, et al.

Publication date: 2007

World Health Organization Definition of "Radiologically Confirmed Pneumonia" May Under-estimate the True Public Health Value of Conjugate Pneumococcal Vaccines

The public health benefit of conjugate pneumococcal vaccine (PCV) in preventing pneumonia would only be appreciated if the tool used for measuring “pneumococcal pneumonia” had good sensitivity. Exploratory studies in South Africa …

Author: Madhi S, Klugman K

Publication date: 2007

World Health Organization Podcast, Episode 45: A New Meningitis Vaccine is Being Introduced to Prevent Epidemics in Sub-Saharan Africa

This podcast discusses the introduction of a new vaccine to prevent epidemics of meningitis in sub-Saharan Africa. The podcast features Dr. Eric Bertherat, from the World Health Organization (WHO) department of Epidemic Pandemic Alert and …

Author: World Health Organization

Publication date: 2008

World Malaria Report

This web page provides links to the annual World Malaria Report, which provides an up-to-date assessment of malaria-related policies adopted and applied in endemic countries, and contains the latest World Health Organization recommendations on …

Author: World Health Organization

Yaounde Declaration on Elimination of Meningococcal Meningitis Type A Epidemics as a Public Health Problem in Africa

This document outlines a pledge made by the ministers of health of African meningitis belt countries at the 58th session of the World Health Organization Regional Committee in Cameroon in 2008 to combat meningococcal disease in the region.

Author: World Health Organization

Publication date: 2008

You Are the Key to HPV Cancer Prevention

This data-rich, hour-long video explores findings which suggest that low human papillomavirus (HPV) vaccination rates are leaving a generation of children vulnerable to HPV cancers. The presentation, which is geared for immunization providers, …

Author: US Centers for Disease Control and Prevention

Publication date: 2014

Page 59 of 59